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eyond a pleural effusion:
rimary pleuropulmonary
arcomas and the challenge of
iagnosis
ear  Editor,
leural  effusion  is  common  in  Pulmonology  but  primary  pleu-
al  neoplastic  causes  are  rare  and  sometimes  difﬁcult  to
iagnose.1
Case  1:  A  50-year-old  ex-smoker  man  with  dyspnea,  right
hest  pain  and  constitutional  symptoms  for  1  month  was
ospitalized  for  pleural  effusion.  The  pleural  ﬂuid  was  an
showed  pleural  lesions,  of  which  biopsies  were  inconclu-
sive.  Video-assisted  thoracoscopic  surgical  pleuropulmonary
biopsy  evidenced  a  mesenchymal  neoplasm  occupant  of
pleura  and  lung  parenchyma,  with  fusocellular  pattern,
at  the  expense  of  cells  with  nuclear  atypia  and  positive
immunostaining  for  vimentin  and  smooth  muscle  actin,  with
a  mitotic  index  less  than  5  mitoses  per  10  HPF  (high-
power  ﬁeld)  under  fasciculated  pattern  with  heterogeneous
deposition  of  a hyaline  matrix  and  slit  like  small  vascular
paths,  corresponding  to  pleuropulmonary  leiomyosarcoma
(Fig.  1C).  Extra-thoracic  lesions  were  not  identiﬁed.  The
rapid  clinical  deterioration  prevented  the  start  of  anti-
neoplastic  therapy  and  the  patient  died  11  weeks  after
admission.e  de
h
p
s
ﬂ
c
nxudate  containing  predominantly  mononuclear  leukocytes,
ormal  adenosine  deaminase  (ADA)  level,  without  microor-
anisms  or  neoplastic  cells.  A  thoracic--abdominal--pelvic
omputerized  tomography  (CT)  demonstrated  right  pleural
ffusion  with  focal  pleural  thickening  (Fig.  1A).  Bronchoﬁ-
roscopy  did  not  show  relevant  changes  and  the  blind  pleural
iopsy  revealed  nonspeciﬁc  pleuritis.  Medical  pleuroscopy
igure  1  Radiological  and  histological  features  observed  in  th
A) Chest  CT  image  demonstrating  a  right  pleural  effusion  with  atele
hickening.
B) Chest  CT  image  revealing  a  left  pleural  effusion  with  associated  
C) Photomicrograph  illustrating  the  presence  of  lung  parenchyma  wi
nd heterogeneously  deposition  of  hyaline  matrix  with  foci  of  hemor
D) Photomicrograph  showing  the  presence  of  pleura  involved  by  ne
nd eosinophilic  cytoplasm,  often  with  vacuoles  and  some  erythroc
00×.scribed  clinical  cases  (Case  1:  A  and  C,  Case  2:  B  and  D).
Case  2:  A  47-year-old  non-smoker  woman  with  recent
istory  of  chest  trauma  was  admitted  due  to  left  chest
ain  and  dyspnea  with  3  months  of  evolution.  The  chest  CT
howed  left  pleural  effusion  (Fig.  1B).  The  hematic  pleural
uid  was  a  lymphocytic  exudate  with  normal  ADA,  without
riteria  for  hemothorax  and  negative  cytology  for  malig-
ancy.  Bronchoﬁbroscopy  did  not  show  relevant  alterationsctasis  of  the  adjacent  lung  parenchyma  and  areas  with  pleural
pulmonary  atelectasis.
th  mesenchymal  neoplasm  in  continuity,  with  expansive  margin
rhage.  Stain:  hematoxylin  and  eosin  (HE);  magniﬁcation:  40×.
oplasia,  composed  of  epithelioid  cells  of  irregular  ovoid  nuclei
ytes  inside.  Stain:  hematoxylin  and  eosin  (HE);  magniﬁcation:
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and  the  blind  pleural  biopsy  revealed  nonspeciﬁc  pleuri-
tis.  Due  to  symptomatic  persistence  and  pleural  thickening
causing  pulmonary  restriction,  she  underwent  pulmonary
decortication  and  parietal  pleurectomy.  Pleural  histologi-
cal  examination  revealed  epithelioid  cells  proliferation  with
atypia  and  positive  for  the  CD34  marker,  favoring  the  diag-
nosis  of  epithelioid  hemangioendothelioma  (Fig.  1D).  The
thoraco--abdominal--pelvic  CT  did  not  show  other  alter-
ations.  Chemotherapy  was  initiated  with  Doxorubicin  but  the
patient  died  after  the  ﬁrst  cycle,  6  months  after  admission.
Primary  thoracic  sarcomas  are  tumors  derived  from
mesenchymal  cells,  they  represent  5%  of  all  thoracic  neo-
plasms  and  may  involve  lung,  pleura  and  mediastinum.2
The  leiomyosarcoma  and  epithelioid  hemangioendothelioma
with  pleuropulmonary  origin  are  two  extremely  rare  types
of  these  tumors  that,  due  to  the  clinical  and  histological
similarity  to  other  pleural  neoplasms,  are  often  difﬁcult
to  diagnose,  with  most  of  the  cases  diagnosed  by  surgi-
cal  biopsy.3,4 The  pleuropulmonary  leiomyosarcoma  usually
presents  as  a  nonspeciﬁc  pleural  mass  and/or  effusion
with  pulmonary  involvement  as  a  well  deﬁned  nodule  with
smooth  margins,  necrotic  mass  or  endobronchial  lesions.2,3
Some  risk  factors  have  been  identiﬁed,  namely  previous
chemotherapy  or  radiation  therapy  and  environmental  or
occupational  exposure.2 It  is  characterized  by  malignant
spindle  cells  with  immunohistochemical  staining  for  smooth
muscle  actin,  vimentin  and  desmin.2,3 The  treatment  of
choice  in  the  limited  disease  is  surgical  resection  asso-
uniformly.4 Compared  to  the  pulmonary  form,  the  pleural
epithelioid  hemangioendothelioma  usually  has  an  aggressive
clinical  course  and  a  poor  prognosis.5,7 The  authors  describe
two  patients  with  rare  causes  of  pleural  effusion,  illustra-
tive  of  the  diagnostic  difﬁculty  and  aggressiveness  of  these
tumors.
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ociated  with  chemotherapy  and/or  radiation  assessed  on
a  case-by-case  basis,  depending  on  the  histological  grade
and  the  clinical  stage.2,3 In  the  advanced  disease  only
chemotherapy  is  recommended.3 The  median  survival  for
patients  with  extensive  disease  is  about  12  months.3 The
pleural  epithelioid  hemangioendothelioma  has  vascular  ori-
gin  and  usually  is  manifested  by  unilateral  pleural  effusion
and  nodular  pleural  thickening.4,5 The  clinical  presentation
is  variable,  however,  chest  pain,  dyspnea  and  cough  are
consistent  symptoms.4 Although  risk  factors  are  unclear,
cases  have  been  described  that  follow  exposure  to  occu-
pational  contaminants,  such  as  rooﬁng  material,  industrial
exposures,  cheese  making,  and  asbestos.6 It  is  charac-
terized  by  cords  and  nests  of  epithelioid  cells  similar  to
endothelial  cells,  associated  with  a  myxohyaline  matrix
and  immunoreactive  for  CD34,  CD31,  vimentin  and  fac-
tor  VIII.2,4 Surgical  resection  is  recommended  but,  when
impracticable,  chemotherapy  has  been  used,  although  not
COPD and physical activity
In  the  general  population,  the  beneﬁts  of  physical  activity
(PA)  are  well  documented,  and  include  primary  prevention
and  control  of  many  chronic  diseases,  such  as  metabolic
or  cardiovascular  disease.  Being  physically  active  preserves
bone  mass  and  muscle  strength,  promotes  well-being,  cog-
nitive  function  and  quality  of  life.  The  American  College
of  Sports  Medicine  states  that  healthy  adults  aged  18--65
years1 need  a  minimum  of  30  min  of  moderate  aerobic  exer-
cise  per  day,  ﬁve  days  a  week,  and  the  British  Association
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f  Sport  and  Exercise  Sciences  advises  at  least  150  min  of
oderate-intensity  aerobic  activity  each  week,  or  75  min
f  vigorous-intensity  aerobic  activity  per  week.2 Adults  not
eeting  these  values  should  be  considered  as  insufﬁciently
ctive.  However,  according  to  GOLD  guidelines,3 PA  is  rec-
mmended  for  all  patients  with  COPD  just  because  it  seems
ntuitively  correct,  given  the  overall  population  beneﬁts,
ut  without  COPD-speciﬁc  evidence  to  support  any  recom-
endations.  On  the  other  hand,  pulmonary  rehabilitation
PR)  has  been  carefully  evaluated:  it  improves  exercise
apacity,  recovery  after  hospitalization  and  reduces  the
